Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.

Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC.

J Clin Oncol. 2012 Jun 20;30(18):2218-26. doi: 10.1200/JCO.2011.38.5740. Epub 2012 May 14.

PMID:
22585699
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care.

Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA.

Breast Cancer Res Treat. 2011 Nov;130(2):619-26. doi: 10.1007/s10549-011-1628-6. Epub 2011 Jun 17.

PMID:
21681446
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.

Dignam JJ.

J Natl Cancer Inst Monogr. 2001;(30):36-43.

PMID:
11773290
[PubMed - indexed for MEDLINE]
4.

21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.

Lund MJ, Mosunjac M, Davis KM, Gabram-Mendola S, Rizzo M, Bumpers HL, Hearn S, Zelnak A, Styblo T, O'Regan RM.

Cancer. 2012 Feb 1;118(3):788-96. doi: 10.1002/cncr.26180. Epub 2011 Jun 30.

PMID:
21720988
[PubMed - indexed for MEDLINE]
Free Article
5.

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.

Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31.

PMID:
18668363
[PubMed - indexed for MEDLINE]
6.

Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention.

Short LJ, Fisher MD, Wahl PM, Kelly MB, Lawless GD, White S, Rodriguez NA, Willey VJ, Brawley OW.

Cancer. 2010 Jan 1;116(1):193-202. doi: 10.1002/cncr.24691.

PMID:
19877115
[PubMed - indexed for MEDLINE]
Free Article
7.

Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer.

Bhargava A, Du XL.

Cancer. 2009 Jul 1;115(13):2999-3008. doi: 10.1002/cncr.24363.

PMID:
19452539
[PubMed - indexed for MEDLINE]
Free Article
8.

Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.

Fedewa SA, Ward EM, Stewart AK, Edge SB.

J Clin Oncol. 2010 Sep 20;28(27):4135-41. doi: 10.1200/JCO.2009.27.2427. Epub 2010 Aug 9.

PMID:
20697082
[PubMed - indexed for MEDLINE]
Free Article
9.

Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.

Sail K, Franzini L, Lairson D, Du X.

Ethn Health. 2012;17(3):309-23. doi: 10.1080/13557858.2011.628011. Epub 2011 Nov 9.

PMID:
22066691
[PubMed - indexed for MEDLINE]
10.

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.

Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, Keating NL.

Cancer. 2011 Jan 1;117(1):180-9. doi: 10.1002/cncr.25542. Epub 2010 Oct 11.

PMID:
20939011
[PubMed - indexed for MEDLINE]
Free Article
11.

A tracking and feedback registry to reduce racial disparities in breast cancer care.

Bickell NA, Shastri K, Fei K, Oluwole S, Godfrey H, Hiotis K, Srinivasan A, Guth AA.

J Natl Cancer Inst. 2008 Dec 3;100(23):1717-23. doi: 10.1093/jnci/djn387. Epub 2008 Nov 25.

PMID:
19033569
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.

Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC.

J Clin Oncol. 2008 Dec 1;26(34):5553-60. doi: 10.1200/JCO.2008.17.9705. Epub 2008 Oct 27.

PMID:
18955448
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer.

Wheeler SB, Carpenter WR, Peppercorn J, Schenck AP, Weinberger M, Biddle AK.

Breast Cancer Res Treat. 2012 Jan;131(1):207-16. doi: 10.1007/s10549-011-1717-6. Epub 2011 Aug 13.

PMID:
21842244
[PubMed - indexed for MEDLINE]
14.

Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.

Hershman DL, Unger JM, Barlow WE, Hutchins LF, Martino S, Osborne CK, Livingston RB, Albain KS.

J Clin Oncol. 2009 May 1;27(13):2157-62. doi: 10.1200/JCO.2008.19.1163. Epub 2009 Mar 23.

PMID:
19307504
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.

Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A, Lipscomb J.

J Clin Oncol. 2012 Jan 10;30(2):142-50. doi: 10.1200/JCO.2011.36.8399. Epub 2011 Dec 5.

PMID:
22147735
[PubMed - indexed for MEDLINE]
Free Article
16.

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.

Susswein LR, Skrzynia C, Lange LA, Booker JK, Graham ML 3rd, Evans JP.

J Clin Oncol. 2008 Jan 1;26(1):32-6. doi: 10.1200/JCO.2007.10.6377.

PMID:
18165638
[PubMed - indexed for MEDLINE]
Free Article
17.

Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.

McCaskill-Stevens W, Wilson J, Bryant J, Mamounas E, Garvey L, James J, Cronin W, Wickerham DL.

J Natl Cancer Inst. 2004 Dec 1;96(23):1762-9. Erratum in: J Natl Cancer Inst. 2005 Jan 5;97(1):71.

PMID:
15572758
[PubMed - indexed for MEDLINE]
Free Article
18.

Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.

Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR, Troxel A, Neugut AI.

J Natl Cancer Inst. 2003 Oct 15;95(20):1545-8.

PMID:
14559877
[PubMed - indexed for MEDLINE]
Free Article
19.

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.

Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE.

J Natl Cancer Inst. 2012 Mar 7;104(5):406-14. doi: 10.1093/jnci/djr543. Epub 2012 Jan 16.

PMID:
22250182
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the U.K.

Holt S, Bertelli G, Humphreys I, Valentine W, Durrani S, Pudney D, Rolles M, Moe M, Khawaja S, Sharaiha Y, Brinkworth E, Whelan S, Jones S, Bennett H, Phillips CJ.

Br J Cancer. 2013 Jun 11;108(11):2250-8. doi: 10.1038/bjc.2013.207. Epub 2013 May 21.

PMID:
23695023
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk